Skip to main navigation Skip to search Skip to main content

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes

  • G. Caocci
  • , M. T. Voso
  • , E. Angelucci
  • , R. Stauder
  • , F. Cottone
  • , G. Abel
  • , K. Nguyen
  • , U. Platzbecker
  • , O. Beyne-Rauzy
  • , G. Gaidano
  • , R. Invernizzi
  • , S. Molica
  • , M. Criscuolo
  • , M. Breccia
  • , M. Lübbert
  • , G. Sanpaolo
  • , F. Buccisano
  • , A. Ricco
  • , G. A. Palumbo
  • , P. Niscola
  • H. Zhang, S. Fenu, G. La Nasa, F. Mandelli, F. Efficace

Research output: Contribution to journalArticlepeer-review

Abstract

Higher-risk myelodysplastic syndromes (MDS) are rarely curable and have a poor prognosis. We investigated the accuracy of physicians' perception of patients' health status and the patients' preferences for involvement in treatment decisions.We examined 280 newly diagnosed higher-risk elderly MDS patients paired with their physicians. Survey tools included the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and the Control Preference Scale.Overall concordance was 49% for physician perception of patient preferences for involvement in treatment decisions. In 36.4% of comparisons there were minor differences and in 14.6% there were major differences. In 44.7% of the patients preferring a passive role, physicians perceived them as preferring an active or collaborative role. Absence of the patient's request for prognostic information ( P = 0.001) and judging the patient as having a poor health status ( P = 0.036) were factors independently associated with the physicians' attitude toward a lower degree of patient involvement in clinical decisions. Agreement on health status was found in 27.5% of cases. Physicians most frequently tended to overestimate health status of patients who reported low-level health status.The value of decision aid-tools in the challenging setting of higher-risk MDS should be investigated to further promote patient-centered care.

Original languageEnglish
Pages (from-to)859-865
Number of pages7
JournalLeukemia Research
Volume39
Issue number8
DOIs
Publication statusPublished - 1 Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer
  • Decision making
  • Health status
  • Hematology
  • Myelodysplastic syndromes
  • Oncology

Fingerprint

Dive into the research topics of 'Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Cite this